AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2018
Dec 7, 2018
30870_dirs_2018-12-07_8cdf4575-b15b-41c5-9a73-d9c3fa95f4f5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2018-12-06
Reporting Person: Malik Fady Ibraham (EVP Research & Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-12-06 | Common Stock | S | 1500 | $7.38 | Disposed | 87067 | Direct |
Footnotes
F1: The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2018.
More from CYTOKINETICS INC
Share Issue/Capital Change
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Share Issue/Capital Change
2026
May 7
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18